-
1دورية أكاديمية
المؤلفون: Vargas, G, Bouchet, M, Bouazza, L, Reboul, P, Boyault, C, Gervais, M, Kan, C, Benetollo, C, Brevet, M, Croset, M, Mazel, M, Cayrefourcq, L, Geraci, S, Vacher, S, Pantano, F, Filipits, M, Driouch, K, Bieche, I, Gnant, M., Jacot, W, Aubin, J.E., Duterque-Coquillaud, M, Alix-Panabières, C, Clézardin, P, Bonnelye, E
المساهمون: Physiopathologie, diagnostic et traitements des maladies osseuses / Pathophysiology, Diagnosis & Treatments of Bone Diseases (LYOS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Génomique Fonctionnelle de Lyon (IGFL), École normale supérieure de Lyon (ENS de Lyon)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire CHU Grenoble (CHUGA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes 2016-2019 (UGA 2016-2019 ), The University of Sydney, Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Institut Curie Paris, Università Campus Bio-Medico di Roma / University Campus Bio-Medico of Rome ( UCBM), Medizinische Universität Wien = Medical University of Vienna, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Department of Biochemistry University of Toronto, University of Toronto, Institut de biologie de Lille - IBL (IBLI), Université de Lille, Sciences et Technologies-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille, Droit et Santé-Centre National de la Recherche Scientifique (CNRS), Mécanismes de la Tumorigénèse et Thérapies Ciblées - UMR 8161 (M3T), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), This work was supported by the National Center for Scientific Research (CNRS) to EB, the National Institute of Health and Medical Research (INSERM), the University of Lyon1, La Ligue Nationale (Drôme), Inserm-Transfert (EB). GV was supported by the Labex DEVweCAN, MG, MB by the French National Cancer Institute (INCa), CK by the Marie-Curie-Individual-Fellowship (655777-miR-OMeS). CAP, LC, and MM by CANCER-ID (FP7/2007-2013) and EFPIA., The authors thank Anne Flourens, Cyprien Tilmant, Tina Louadj, and both CeCIL and ALECS platforms (Faculté de Médecine Laennec, Lyon) for their assistance., ANR-10-LABX-0061,DEVWECAN,Development Cancer and Targeted Therapies(2010)
المصدر: ISSN: 0950-9232.
مصطلحات موضوعية: MESH: Animals, MESH: Bone Neoplasms/genetics, MESH: Breast Neoplasms/metabolism, MESH: Breast Neoplasms/pathology, MESH: Humans, MESH: Female, MESH: Gene Expression Regulation, Neoplastic, MESH: Mammary Neoplasms, Animal/genetics, Animal/metabolism, Animal/pathology, MESH: Mice, Inbred BALB C, MESH: Receptor Activator of Nuclear Factor-kappa B/biosynthesis, MESH: Neoplasm Proteins/genetics, MESH: Neoplasm Proteins/metabolism, MESH: Receptor Activator of Nuclear Factor-kappa B/genetics, MESH: Bone Neoplasms/metabolism, MESH: Receptors, Estrogen/genetics, Estrogen/metabolism, MESH: Bone Neoplasms/pathology, MESH: Breast Neoplasms/genetics, MESH: Bone Neoplasms/secondary, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30478447; hal-02353108; https://hal.science/hal-02353108Test; https://hal.science/hal-02353108/documentTest; https://hal.science/hal-02353108/file/Vargas%20et%20al-2019.pdfTest; PUBMED: 30478447
الإتاحة: https://doi.org/10.1038/s41388-018-0579-3Test
https://hal.science/hal-02353108Test
https://hal.science/hal-02353108/documentTest
https://hal.science/hal-02353108/file/Vargas%20et%20al-2019.pdfTest -
2
المؤلفون: Irla, Magali
المساهمون: Centre d'Immunologie de Marseille - Luminy (CIML), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), DUMENIL, Anita, Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), ANR-19-CE18-0021,RANKLthym,Évaluer le potentiel de RANK ligand pour rétablir des fonctions thymiques efficaces après greffe de moelle osseuse et vieillissement(2019)
المصدر: Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 11, ⟨10.3389/fimmu.2020.623265⟩
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology, 2021, 11, ⟨10.3389/fimmu.2020.623265⟩مصطلحات موضوعية: central tolerance, lcsh:Immunologic diseases. Allergy, Thymocytes, Receptor Activator of Nuclear Factor-kappa B, Mini Review, bone marrow transplantation, [SDV]Life Sciences [q-bio], RANK Ligand, Immunology, education, Epithelial Cells, hemic and immune systems, Thymus Gland, [SDV] Life Sciences [q-bio], thymic regeneration, thymic crosstalk, thymic epithelial cells, Humans, Regeneration, receptor activator of nuclear factor kappa-B, lcsh:RC581-607, tissues, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::10423e284fb88833354f47a3f29a7190Test
https://hal-amu.archives-ouvertes.fr/hal-03375328Test -
3
المؤلفون: Vakili, Ludmilla
المساهمون: Université Côte d'Azur - Faculté de Chirurgie Dentaire (UCA Faculté Odontologie), Université Côte d'Azur (UCA), Christine Voha
المصدر: Médecine humaine et pathologie. 2020
مصطلحات موضوعية: Parodonte, Immunité adaptative, Immunité innée, Neutrophiles, Receptor activator of nuclear factor kappa-B ligand (RANKL), Parodontite, Lymphocytes, Ostéoimmunologie, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2592::0c02d1eb9ac31473bf04bb16168369bcTest
https://dumas.ccsd.cnrs.fr/dumas-03068266/documentTest -
4دورية أكاديمية
المؤلفون: Mori, Kanji, Ando, K., Heymann, Dominique, Rédini, Françoise
المساهمون: Department of Orthopaedic Surgery, Shiga University of Medical Science, Service d'orthopédie-traumatologie, Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: ISSN: 0213-3911 ; Histology and Histopathology ; https://inserm.hal.science/inserm-00667499Test ; Histology and Histopathology, 2009, 24 (2), pp.235-42.
مصطلحات موضوعية: RANK, RANKL, Bone metastasis, Migration, MESH: Apoptosis, MESH: Models, Biological, MESH: Neoplasm Metastasis, MESH: Neoplasms, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: Animals, MESH: Bone Neoplasms, MESH: Bone and Bones, MESH: Cell Movement, MESH: Female, MESH: Gene Expression Regulation, Neoplastic, MESH: Humans, MESH: Male, MESH: Mice, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/19085839; inserm-00667499; https://inserm.hal.science/inserm-00667499Test; https://inserm.hal.science/inserm-00667499/documentTest; https://inserm.hal.science/inserm-00667499/file/Mori_et_al_Histol_Histopathol_2009.pdfTest; PUBMED: 19085839
-
5رسالة جامعية
المؤلفون: Vakili, Ludmilla
المساهمون: Université Côte d'Azur - Faculté de Chirurgie Dentaire (UCA Faculté Odontologie), Université Côte d'Azur (UniCA), Christine Voha
المصدر: https://dumas.ccsd.cnrs.fr/dumas-03068266Test ; Médecine humaine et pathologie. 2020.
مصطلحات موضوعية: Receptor activator of nuclear factor kappa-B ligand (RANKL), Parodonte, Immunité innée, Parodontite, Immunité adaptative, Ostéoimmunologie, Neutrophiles, Lymphocytes, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
العلاقة: dumas-03068266; https://dumas.ccsd.cnrs.fr/dumas-03068266Test; https://dumas.ccsd.cnrs.fr/dumas-03068266/documentTest; https://dumas.ccsd.cnrs.fr/dumas-03068266/file/2020NICED022.pdfTest
-
6دورية أكاديمية
المؤلفون: Duplomb, Laurence, Baud'Huin, Marc, Charrier, Céline, Berreur, Martine, Trichet, Valérie, Blanchard, Frédéric, Heymann, Dominique
المساهمون: Physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), This work was supported by the Région des Pays de la Loire (Program entitled "Ciblage Moléculaire et Applications Thérapeutique") and the Agence Nationale de la Recherche 2007 Institut National de la Santé et de la Recherche Médicale Pathophysiology of Human Deseases Project No. R07196NS. L.D. has been supported by an Association pour la Recherche sur le Cancer postdoctoral fellowship
المصدر: ISSN: 0013-7227 ; Endocrinology ; https://inserm.hal.science/inserm-00667501Test ; Endocrinology, 2008, 149 (7), pp.3688-97. ⟨10.1210/en.2007-1719⟩.
مصطلحات موضوعية: MESH: Antigens, CD11b, MESH: Interleukin-6, MESH: Macrophages, MESH: Mice, MESH: Models, Biological, MESH: Monocytes, MESH: Osteoclasts, MESH: Phosphorylation, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: Reverse Transcriptase Polymerase Chain Reaction, CD14, MESH: STAT3 Transcription Factor, MESH: Serine, MESH: Animals, MESH: Blotting, Western, MESH: Bone Marrow Cells, MESH: Cell Differentiation, MESH: Cell Line, MESH: Flow Cytometry, MESH: Gene Expression, MESH: Humans, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/18403479; inserm-00667501; https://inserm.hal.science/inserm-00667501Test; https://inserm.hal.science/inserm-00667501/documentTest; https://inserm.hal.science/inserm-00667501/file/Duplomb_et_al_Endocrinology_2008.pdfTest; PUBMED: 18403479
الإتاحة: https://doi.org/10.1210/en.2007-1719Test
https://inserm.hal.science/inserm-00667501Test
https://inserm.hal.science/inserm-00667501/documentTest
https://inserm.hal.science/inserm-00667501/file/Duplomb_et_al_Endocrinology_2008.pdfTest -
7دورية أكاديمية
المؤلفون: Mori, Kanji, Berreur, Martine, Blanchard, Fréderic, Chevalier, Catherine, Guisle-Marsollier, Isabelle, Masson, Martial, Rédini, Françoise, Heymann, Dominique
المساهمون: Physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie et pharmacologie cellulaires et moléculaires, Laboratoire d'ingénierie osteo-articulaire et dentaire (LIOAD), IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR Odontologie (UFR Odonto), Université de Nantes (UN)-Université de Nantes (UN), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), This work was supported by The Région des Pays de la Loire and by a grant from the West Committee of the Ligue Contre le Cancer. Kanji Mori received a personal fellowship from the Ligue Nationale Contre le Cancer.
المصدر: ISSN: 1021-335X.
مصطلحات موضوعية: RANK, RANKL, osteosarcoma, bone tumor, bone microenvironment, gene modulation, MESH: Cell Division, MESH: Osteoblasts, MESH: Osteoclasts, MESH: Osteosarcoma, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: Reverse Transcriptase Polymerase Chain Reaction, MESH: Bone Neoplasms, MESH: Cell Line, Tumor, MESH: Cell Movement, MESH: Cell Survival, MESH: Gene Expression Profiling, MESH: Gene Expression Regulation, Neoplastic, MESH: Humans, MESH: Oligonucleotide Array Sequence Analysis, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/17982618; inserm-00667508; https://inserm.hal.science/inserm-00667508Test; https://inserm.hal.science/inserm-00667508/documentTest; https://inserm.hal.science/inserm-00667508/file/Mori_et_al_Oncol_Rep_2007.pdfTest; PUBMED: 17982618
-
8دورية أكاديمية
المؤلفون: Mori, Kanji, Le Goff, Benoît, Charrier, Céline, Battaglia, Séverine, Heymann, Dominique, Rédini, Françoise
المساهمون: Physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by INSERM, The Région des Pays de la Loire and by a grant from the West Committee of the Ligue Contre le Cancer. Kanji Mori received a personal fellowship from the Ligue Nationale Contre le Cancer.
المصدر: ISSN: 8756-3282.
مصطلحات موضوعية: RANK, RANKL, prostate cancer, migration, bone metastasis, MESH: 3T3 Cells, MESH: Animals, MESH: Models, Biological, MESH: Osteoblasts, MESH: Osteoclasts, MESH: Osteoprotegerin, MESH: Prostatic Neoplasms, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: Recombinant Proteins, MESH: STAT3 Transcription Factor, MESH: Signal Transduction, MESH: Bone Neoplasms, MESH: Cell Line, Tumor, MESH: Culture Media, Conditioned, MESH: Humans, MESH: I-kappa B Proteins, MESH: MAP Kinase Signaling System, MESH: Male, MESH: Mice, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/17196895; inserm-00667539; https://www.hal.inserm.fr/inserm-00667539Test; https://www.hal.inserm.fr/inserm-00667539/documentTest; https://www.hal.inserm.fr/inserm-00667539/file/Mori_et_al_Bone.pdfTest; PUBMED: 17196895
الإتاحة: https://doi.org/10.1016/j.bone.2006.11.006Test
https://www.hal.inserm.fr/inserm-00667539Test
https://www.hal.inserm.fr/inserm-00667539/documentTest
https://www.hal.inserm.fr/inserm-00667539/file/Mori_et_al_Bone.pdfTest -
9دورية أكاديمية
المؤلفون: Brazier, Hélène, Stephens, Sébastien, Ory, Stéphane, Fort, Philippe, Morrison, Nigel, Blangy, Anne
المساهمون: Centre de recherches de biochimie macromoléculaire (CRBM), Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Centre National de la Recherche Scientifique (CNRS), School of Medical Science, Griffith University Brisbane
المصدر: ISSN: 0884-0431.
مصطلحات موضوعية: MESH: Adaptor Proteins, Signal Transducing, MESH: Animals, MESH: Gene Expression Profiling, MESH: Guanine Nucleotide Exchange Factors, MESH: Humans, MESH: Membrane Glycoproteins, MESH: Mice, Inbred C57BL, MESH: NIH 3T3 Cells, MESH: Osteoclasts, MESH: Phosphoproteins, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: rho GTP-Binding Proteins, MESH: Carrier Proteins, MESH: Cell Differentiation, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BDD.EO]Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis, [SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics, Phylogenetics and taxonomy, [SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/16939397; hal-00189080; https://hal.science/hal-00189080Test; https://hal.science/hal-00189080/documentTest; https://hal.science/hal-00189080/file/HBrazier_JBMR2006.pdfTest; PUBMED: 16939397
الإتاحة: https://doi.org/10.1359/jbmr.060613Test
https://hal.science/hal-00189080Test
https://hal.science/hal-00189080/documentTest
https://hal.science/hal-00189080/file/HBrazier_JBMR2006.pdfTest -
10دورية أكاديمية
المؤلفون: Wittrant, Y., Lamoureux, François, Mori, Kanji, Riet, Anne, Kamijo, Akira, Heymann, Dominique, Rédini, Françoise
المساهمون: Physiopathologie de la résorption osseuse et thérapie des tumeurs osseuses primitives, Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of orthopaedic surgery, Yokohama City University (YCU), This work was supported by the Ministère de la Recherche (ACI no. TS/0220044) and the 'Comité des Pays de Loire de la Ligue Contre le Cancer' (K. Mori received a fellowship from the 'Ligue Nationale Contre le Cancer').
المصدر: ISSN: 1019-6439.
مصطلحات موضوعية: osteosarcoma, bone tumors, RANK, RANKL, BMP-2, MESH: Animals, MESH: Bone Morphogenetic Protein 2, MESH: Mice, Inbred C3H, MESH: Osteosarcoma, MESH: RANK Ligand, MESH: Receptor Activator of Nuclear Factor-kappa B, MESH: Reverse Transcriptase Polymerase Chain Reaction, MESH: Signal Transduction, MESH: Transforming Growth Factor beta, MESH: Tumor Cells, Cultured, MESH: Bone Morphogenetic Proteins, MESH: Bone Neoplasms, MESH: Carrier Proteins, MESH: Cell Proliferation, MESH: Gene Expression Profiling, MESH: Humans, MESH: Lung Neoplasms, MESH: Membrane Glycoproteins, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/16328004; inserm-00667510; https://inserm.hal.science/inserm-00667510Test; https://inserm.hal.science/inserm-00667510/documentTest; https://inserm.hal.science/inserm-00667510/file/Wittrant_et_al_Int_J_Oncol_2006.pdfTest; PUBMED: 16328004